EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR)

CUSIP: G3141W106

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / SHS
Total 13F shares
985,691
Share change
+985,691
Total reported value
$9,906,000
Price per share
$10.05
Number of holders
5
Value change
+$9,905,990
Number of buys
5

Quarterly Holders Quick Answers

What is CUSIP G3141W106?
CUSIP G3141W106 identifies EUCR - EUCRATES BIOMEDICAL ACQU COR - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) as of Q4 2020

As of 31 Dec 2020, EUCRATES BIOMEDICAL ACQU COR - SHS (EUCR) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 985,691 shares. The largest 5 holders included Charles Winkler, Granite Point Capital Management, L.P., Radcliffe Capital Management, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, and WOLVERINE ASSET MANAGEMENT LLC. This page lists 5 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.